PMC:7307149 / 16540-17477
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T109 | 62-65 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T110 | 219-222 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T111 | 232-235 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T112 | 245-248 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T113 | 262-265 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T114 | 507-510 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T115 | 520-523 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T116 | 537-540 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T72 | 23-31 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T73 | 124-132 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T74 | 335-343 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T75 | 403-411 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T76 | 616-624 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T77 | 775-783 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T174 | 34-41 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
T175 | 135-142 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
T176 | 236-237 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T177 | 249-250 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T178 | 414-421 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
T179 | 511-512 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T180 | 524-525 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T181 | 786-794 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptides |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T96 | 34-41 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
T97 | 135-142 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
T98 | 414-421 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
T99 | 586-593 | Chemical | denotes | epitope | http://purl.obolibrary.org/obo/CHEBI_53000 |
T100 | 786-794 | Chemical | denotes | peptides | http://purl.obolibrary.org/obo/CHEBI_16670 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
320 | 232-237 | Gene | denotes | HLA-A | Gene:3105 |
321 | 245-250 | Gene | denotes | HLA-B | Gene:3106 |
322 | 262-267 | Gene | denotes | HLA-C | Gene:3107 |
323 | 507-512 | Gene | denotes | HLA-A | Gene:3105 |
324 | 520-525 | Gene | denotes | HLA-B | Gene:3106 |
325 | 537-542 | Gene | denotes | HLA-C | Gene:3107 |
326 | 23-33 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
327 | 124-134 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
328 | 335-345 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
329 | 403-413 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
330 | 616-626 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
331 | 775-785 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T90 | 0-77 | Sentence | denotes | FIG 6 Distributions of SARS-CoV-2 peptide presentation across HLA haplotypes. |
T91 | 78-355 | Sentence | denotes | The leftmost panels show the distributions of SARS-CoV-2 peptide presentation capacity for haplotypes containing one of three representative HLA alleles (HLA-A*02:02, HLA-B*15:03, and HLA-C*12:03) with the greatest predicted repertoire of epitopes from the SARS-CoV-2 proteome. |
T92 | 356-636 | Sentence | denotes | The rightmost panels show the distributions of SARS-CoV-2 peptide presentation capacity for haplotypes containing one of three representative alleles (HLA-A*25:01, HLA-B*46:01, and HLA-C*01:02) with the lowest predicted levels of epitope presentation from the SARS-CoV-2 proteome. |
T93 | 637-709 | Sentence | denotes | Black and gray bars represent full and partial haplotypes, respectively. |
T94 | 710-937 | Sentence | denotes | Blue and red dashed lines represent the percentages of presented SARS-CoV-2 peptides for the indicated allele itself (blue) and its global population frequency weighted average presentation across its observed haplotypes (red). |